Showing results (801-810 of 1,024) with videos related to

Sort By:
Pageof 103
Hepatology (Baltimore, Md.)|November 20, 2020
Factors Associated With Hepatitis A Mortality During Person-to-Person Outbreaks: A Matched Case-Control Study-United States, 2016-2019Megan G Hofmeister, Jian Xing, Monique A Foster, et al.
The Journal of Infectious Diseases|October 24, 2020
Hepatitis A Person-to-Person Outbreaks: Epidemiology, Morbidity Burden, and Factors Associated With Hospitalization-Multiple States, 2016-2019Megan G Hofmeister, Jian Xing, Monique A Foster, et al.
Journal of Medical Economics|August 23, 2022
Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysisCarina Blomström Lundqvist, Sara Själander, Luis A Garcia Rodriguez, et al.
Scientific Reports|May 7, 2020
Development of a new macrophage-specific TRAP mouse (Mac<sup>TRAP</sup>) and definition of the renal macrophage translational signatureAndreas Hofmeister, Maximilian C Thomaßen, Sabrina Markert, et al.
Leukemia Research|October 7, 2008
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cellsSandrine d'Argouges, Sandra Wissing, Christian Brandl, et al.
Hypertension (Dallas, Tex. : 1979)|July 15, 2009
Pharmacological characterization of SAR407899, a novel rho-kinase inhibitorMatthias Löhn, Oliver Plettenburg, Yuri Ivashchenko, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Addition of infliximab to standard acute graft-versus-host disease prophylaxis following allogeneic peripheral blood cell transplantationMehdi Hamadani, Craig C Hofmeister, Buffy Jansak, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 8, 2014
Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindredYvonne A Efebera, Amy Sturm, Elizabeth C Baack, et al.
Blood|October 4, 2012
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myelomaDon M Benson, Craig C Hofmeister, Swaminathan Padmanabhan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple MyelomaNisha S Joseph, Jonathan L Kaufman, Madhav V Dhodapkar, et al.
Pageof 103